Drug: velcade Quarter: 2016Q3
Total Records: 602 Number of Pages: 31
| DRUGNAME | PT | EventCount |
|---|---|---|
| VELCADE | Hypovolaemic shock | 1 |
| VELCADE | Hypoxic-ischaemic encephalopathy | 1 |
| VELCADE | Immune system disorder | 1 |
| VELCADE | Impaired gastric emptying | 1 |
| VELCADE | Injection site discomfort | 1 |
| VELCADE | Injection site exfoliation | 1 |
| VELCADE | Injection site infection | 1 |
| VELCADE | Injury | 1 |
| VELCADE | Intestinal perforation | 1 |
| VELCADE | Irritable bowel syndrome | 1 |
| VELCADE | Joint swelling | 1 |
| VELCADE | Keratitis | 1 |
| VELCADE | Lacrimation increased | 1 |
| VELCADE | Lactic acidosis | 1 |
| VELCADE | Lipids increased | 1 |
| VELCADE | Lumbar radiculopathy | 1 |
| VELCADE | Lyme disease | 1 |
| VELCADE | Lymphocytic leukaemia | 1 |
| VELCADE | Mantle cell lymphoma recurrent | 1 |
| VELCADE | Mantle cell lymphoma refractory | 1 |
Total Records: 602 Number of Pages: 31